Metabolic & Cardiometabolic

combined oral contraceptive decreases hyperandrogenism

Strong support Metabolic & Cardiometabolic

RefutedContestedStrong support

consensus score 0.84

📅 Last reviewed: 2026-07-15 ⓘ

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

8 support 0 contradict 0 tested null 1 mixed · 9 sources, 8 independent groups

What the evidence shows

Combined oral contraceptives reduce hyperandrogenism in PCOS (raise SHBG, lower free androgen index / testosterone) — superior to metformin on this axis.

Cochrane has no ruling yet see how our grade compares ▾

Cochrane review 2015 · limited quality (authors' wording) for mild hirsutism Not directly comparable

Outcome is the Ferriman-Gallwey hirsutism score, a clinical manifestation, rather than biochemical androgen levels.

“Interventions for hirsutism excluding laser and photoepilation therapy alone (Cochrane CD010334.pub2, 2015). Assesses oral contraceptive pills (ethinyl estradiol + cyproterone acetate vs ethinyl estradiol + desogestrel) on change from baseline in Ferriman-Gallwey scores. Authors' conclusions: 'For mild hirsutism there is evidence of limited quality...'”

Not directly comparable: their review asks a different question or reports an outcome we do not grade, so it neither corroborates nor contradicts this claim.

What is Cochrane, and why trust it?

Cochrane produces systematic reviews: instead of running a new study, they gather every trial ever done on a question, judge how well each was run, and pool the results. They take no commercial or industry funding, which is why the medical community treats their reviews as a gold standard — and why we check our own verdicts against theirs.

About Cochrane ↗ · Get involved / support ↗

Read the Cochrane review ↗

The evidence (9)

Source	Grade	Stance	Quality	Finding
Nolte J et al 2026 · study_type: observational	observational	supports	low	Prospective cohort of 22 elite female athletes (7 on hormonal contraception, 15 naturally cycling); COC users showed significantly suppressed urinary testosterone vs naturally cycling women (2.55±2.91 vs 5.45±4.31 ng/mL, p<0.001). Contracep
Melin J, et al. 2024 · J Clin Endocrinol Metab	meta-analysis	supports	high	Pooled (36 RCTs, GRADE): COCP superior to metformin on all three hyperandrogenism markers (FAI, SHBG, testosterone), CIs excluding null.
Abdalla 2023 · Arch Gynecol Obstet	meta-analysis	supports	moderate	MA of RCTs: COCPs significantly reduce biochemical hyperandrogenemia in PCOS
Frank GR. 2026 · study_type: observational	observational	supports	low	n=1 case: adolescent with ovarian hyperthecosis, testosterone 498 ng/dL normalized to 22 ng/dL over 10 months on COC; discontinuation caused relapse to 571 ng/dL, reinitiation renormalized it. Formulation unspecified.
Alesi 2023 · eClinicalMedicine	meta-analysis	mixed	moderate	MA for 2023 PCOS guideline: COCPs reduce clinical/biochemical hyperandrogenism (raise SHBG, lower free androgens) ⚠️ correction-on-file (Crossref) - kept, corrigendum not retraction
Aksun S et al 2025 · study_type: observational	observational	supports	moderate	Prospective study, n=20 PCOS women (vs 20 matched controls); after ≥3 cycles of oral contraceptive therapy, total testosterone and free androgen index (FAI) significantly decreased (p=0.02 and p<0.0001 respectively) with no change in muscle
Lobo R et al 2025 · study_type: RCT	RCT	supports	high	Multicentre double-blind placebo-controlled RCT, n=256 (FAS: 209 DNG+EE vs 47 placebo) with PCOS-associated hirsutism; dienogest 2mg + ethinylestradiol 0.02mg (24/4 regimen) reduced adapted Ferriman-Gallwey score by -3.8 vs -1.5 for placebo
Amiri 2020 · Hum Reprod	RCT	supports	moderate	Crossover RCT: oral contraceptives lower androgens and raise SHBG in PCOS
cocp-oral-vaginal-2023 2023	RCT	supports	moderate	RCT (n=24): oral and vaginal combined contraceptives both raised SHBG and lowered androgens in PCOS (plus unfavorable metabolic shifts).

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.